Tag: value

Dubai, June 26, 2026 (GLOBE NEWSWIRE) -- Reference is made to the stock exchange announcement released 23 June 2026 by Vantage Drilling International Ltd. (the "Company"), regarding the intention to repurchase own shares prior to completion of a merger pursuant to which a wholly owned subsidiary of Eldorado Drilling AS is to merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Eldorado Drilling AS (the "Merger").

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today its shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4^th floor, 75013 Paris, France.

EATONTOWN, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, today announced that the Company’s Board of Directors (the “Board”) has elected Peter Bell to the Board. With the election of Mr. Bell, Climb’s Board increased to five total members, four of whom are independent under the Nasdaq listing standards. Mr. Bell will serve as the Chair of the Nominating and Corporate Governance Committee.

Bridging the Gap Between Making Money and Actually Building Wealth

Addition reflects Eikon's progress as a publicly traded company and increasing visibility within the investment community

 ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production